Abstract：
OBJECTIVE: Renal Cell Carcinoma (RCC) with invasion into the inferior vena cava (IVC) is a rare and mortal condition. Patients with RCC have an average life expectancy of no more than six months, thus requiring an aggressive surgical approach. We analyze the outcomes of patients that underwent surgery at a single medical institution.
RESULTS: The analysis of recent series of successful treatment with radical nephrectomy and IVC thrombectomy shows a 5 year survival from 45 to 69%. We found in the analyzed series that the success of the treatment in these patients depends on the resection of the renal tumor and venous thrombectomy. We found that at our medical institution nephrectomy and IVC thrombectomy with primary repair have no intraoperative mortality and no pulmonary embolism. Nephrectomy and thrombectomy of IVC is a reliable approach for patients with advance RCC.
RESULTS: The analysis of recent series of successful treatment with radical nephrectomy and IVC thrombectomy shows a 5 year survival from 45 to 69%. We found in the analyzed series that the success of the treatment in these patients depends on the resection of the renal tumor and venous thrombectomy. We found that at our medical institution nephrectomy and IVC thrombectomy with primary repair have no intraoperative mortality and no pulmonary embolism. Nephrectomy and thrombectomy of IVC is a reliable approach for patients with advance RCC.
摘要：
目的：侵犯下腔静脉（IVC）的肾细胞癌（RCC）是一种罕见且致命的疾病。RCC患者的平均寿命不超过6个月,因此需要积极的手术方法。我们分析了在单一医疗机构接受手术的患者的结果。
结果：对根治性肾切除术和IVC血栓切除术的一系列成功治疗的分析显示，5年生存率为45％至69％。我们在分析系列中发现，这些患者的治疗成功取决于肾肿瘤的切除和静脉血栓切除术。我们发现，在我们的医疗机构进行肾切除术和IVC血栓切除术并进行初次修复没有术中死亡率和肺栓塞。肾切除术和IVC血栓切除术是晚期RCC患者的可靠方法。
结果：对根治性肾切除术和IVC血栓切除术的一系列成功治疗的分析显示，5年生存率为45％至69％。我们在分析系列中发现，这些患者的治疗成功取决于肾肿瘤的切除和静脉血栓切除术。我们发现，在我们的医疗机构进行肾切除术和IVC血栓切除术并进行初次修复没有术中死亡率和肺栓塞。肾切除术和IVC血栓切除术是晚期RCC患者的可靠方法。
